Xenon Pharmaceuticals Inc.
XENE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $143 | $149 | $57 | $176 |
| Short-Term Investments | $484 | $489 | $535 | $376 |
| Receivables | $1 | $1 | $1 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $6 | $7 | $4 |
| Total Curr. Assets | $635 | $645 | $600 | $559 |
| Property Plant & Equip (Net) | $18 | $19 | $17 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $127 | $293 | $129 | $0 |
| Tax Assets | $10 | $1 | $1 | $0 |
| Other NC Assets | $7 | $7 | $8 | $0 |
| Total NC Assets | $163 | $320 | $154 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $798 | $965 | $754 | $572 |
| Liabilities | – | – | – | – |
| Payables | $5 | $9 | $8 | $4 |
| Short-Term Debt | $1 | $1 | $0 | $1 |
| Tax Payable | $6 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $23 | $17 | $14 | $10 |
| Total Curr. Liab. | $36 | $27 | $23 | $14 |
| LT Debt | $8 | $10 | $10 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $10 | $10 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $11 | $10 | $8 |
| Total Liabilities | $43 | $37 | $33 | $22 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $8 |
| Common Stock | $1,457 | $1,436 | $1,065 | $783 |
| Retained Earnings | -$899 | -$665 | -$483 | -$357 |
| AOCI | -$2 | -$0 | -$3 | -$1 |
| Other Equity | $199 | $157 | $142 | $117 |
| Total Equity | $755 | $928 | $721 | $550 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $798 | $965 | $754 | $572 |
| Net Debt | -$134 | -$138 | -$47 | -$167 |